Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject^® Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract

Inder Paul Singh1 The Eyes Centers of Racine & Kenosha, Racine, WI, USACorrespondence[email protected]
View further author information

Steven Sarkisian Jnr2 Oklahoma Eye Surgeons, Oklahoma City, OK, USAView further author information

Dana Hornbeak3 Glaukos Corporation, San Clemente, CA, USAView further author information

L Jay Katz3 Glaukos Corporation, San Clemente, CA, USA;4 Wills Eye Hospital, Philadelphia, PA, USAView further author information

Thomas Samuelson5 Minnesota Eye Consultants, Minneapolis, MN, USAView further author information

& for the iStent inject Study Group

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Louis Cantor, Dan Lindfield, Federico Ghinelli, Anna W Świder, Francesca Torelli, Carolyn Steeds, Jaime E Dickerson Jr & Dan Q Nguyen. (2023) Systematic Literature Review of Clinical, Economic, and Humanistic Outcomes Following Minimally Invasive Glaucoma Surgery or Selective Laser Trabeculoplasty for the Treatment of Open-Angle Glaucoma with or Without Cataract Extraction. Clinical Ophthalmology 17, pages 85-101.
Read now

Articles from other publishers (3)

Colin Clement, Frank Howes, Alexandros Ioannidis, Michael Shiu, David Manning, Jed A Lusthaus, Simon E Skalicky & Todd W Goodwin. (2022) Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension. Clinical Ophthalmology Volume 16, pages 2955-2968.
Crossref

Fritz H. Hengerer, Gerd U. Auffarth & Ina Conrad-Hengerer. (2022) iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control. Advances in Therapy 39:3, pages 1417-1431.
Crossref

Seungsoo Rho & Su-Ho Lim. (2021) Clinical Outcomes After Second-Generation Trabecular Microbypass Stents (iStent inject®) with Phacoemulsification in Korean Patients. Ophthalmology and Therapy 10:4, pages 1105-1117.
Crossref

Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject^® Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject® Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract

Citations (4)

Read on this site (1)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Treatment Success Across Different Levels of Preoperative Disease Burden: Stratified Two-Year Outcomes from the Pivotal Trial of iStent inject^® Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract